CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Intuitive Surgical Inc Stock (ISRG) Moved Up by 7.01% on Apr 22: What Investors Need To Know

Source Tradingkey

Intuitive Surgical Inc (ISRG) moved up by 7.01%. The Healthcare Services & Equipment sector is up by 1.39%. The company outperformed the industry. Top 3 stocks by turnover in the sector: Unitedhealth Group Inc (UNH) up 2.21%; Intuitive Surgical Inc (ISRG) up 7.01%; Boston Scientific Corp (BSX) up 7.64%.

SummaryOverview

What is driving Intuitive Surgical Inc (ISRG)’s stock price up today?

Intuitive Surgical's stock experienced significant upward movement, primarily driven by its robust first-quarter 2026 financial results, which substantially exceeded market expectations. The company reported strong performance in both revenue and earnings per share, with revenue increasing by a notable percentage year-over-year. Non-GAAP earnings also showed a significant increase, surpassing analyst consensus estimates.

Adding to the positive sentiment, Intuitive Surgical raised its full-year 2026 guidance for worldwide da Vinci procedure growth. The updated forecast for procedure growth indicates increased confidence from management in the company's operational strength and market adoption. Furthermore, the outlook for non-GAAP gross profit margin was also improved.

The company highlighted strong procedure volumes, noting significant growth in both da Vinci and Ion procedures. This indicates expanding utilization and acceptance of its robotic-assisted surgical platforms globally. The successful placement of a substantial number of da Vinci 5 systems in the quarter also contributed to the positive financial narrative.

Following the strong earnings announcement and revised guidance, several financial analysts reiterated their positive ratings on Intuitive Surgical's stock, with some adjusting price targets upwards. This general reaffirmation of confidence from the analyst community further bolstered investor sentiment. Additionally, recent FDA clearance for expanded uses of Force Feedback instruments for the da Vinci systems, along with the launch of a new da Vinci Xi Surgical System, likely contributed to the positive market reaction by signaling continued product innovation and market expansion.

Technical Analysis of Intuitive Surgical Inc (ISRG)

Technically, Intuitive Surgical Inc (ISRG) shows a MACD (12,26,9) value of [-7.10], indicating a neutral signal. The RSI at 40.74 suggests neutral condition and the Williams %R at -86.74 suggests oversold condition. Please monitor closely.

Media Coverage of Intuitive Surgical Inc (ISRG)

In terms of media coverage, Intuitive Surgical Inc (ISRG) shows a coverage score of 49, indicating a moderate level of media attention. The overall market sentiment index is currently in bullish zone.

SentimentAnalysis

Fundamental Analysis of Intuitive Surgical Inc (ISRG)

Intuitive Surgical Inc (ISRG) is in the Healthcare Services & Equipment industry. Its latest annual revenue is $10.06B, ranking 15 in the industry. The net profit is $2.86B, ranking 7 in the industry. Company Profile

FundamentalAnalysis

Over the past month, multiple analysts have rated the company as Buy, with an average price target of $596.30, a high of $750.00, and a low of $440.00.

More details about Intuitive Surgical Inc (ISRG)

Company Specific Risks:

  • Increased regulatory scrutiny and potential liabilities stemming from recent FDA safety alerts and voluntary recalls of da Vinci instruments and curved tip staplers linked to serious injuries and fatalities.
  • Intensifying competitive pressures, particularly in China, where provincial tenders are showing preferences for local suppliers and lower pricing, impacting market share and growth.
  • Analyst downgrades and concerns over elevated valuation multiples, with several firms revising price targets downward, signaling potential for further stock price adjustments.
  • Company guidance projecting a deceleration in da Vinci procedure growth for 2026 compared to 2025, alongside anticipated margin compression from tariffs impacting profitability.
Disclaimer: The content available on Mitrade Insights is provided for informational and marketing purposes only. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research
Nothing in this material constitutes investment advice, personal recommendation, investment research, an offer, or a solicitation to buy or sell any financial instrument. The content has been prepared without consideration of your individual investment objectives, financial situation, or needs, and should not be treated as such.
Past performance is not a reliable indicator of future performance and/or results. Forward-looking scenarios or forecasts are not a guarantee of future performance. Actual results may differ materially from those anticipated.
Mitrade makes no representation or warranty as to the accuracy or completeness of the information provided and accepts no liability for any loss arising from reliance on such information.
placeholder
Financial Markets 2026: Volatility Catalysts in Gold, Silver, Oil, and Blue-Chip Stocks—A CFD Trader's OutlookThe financial world is perpetually in motion, but the landscape for 2026 seems to be shaping up to be particularly dynamic. For CFD traders navigating global markets, this heightened volatility could present a distinctive set of challenges and opportunities.
Author  Rachel Weiss
Mar 05, Thu
The financial world is perpetually in motion, but the landscape for 2026 seems to be shaping up to be particularly dynamic. For CFD traders navigating global markets, this heightened volatility could present a distinctive set of challenges and opportunities.
placeholder
Silver Price Forecast: XAG/USD bulls seem hesitant below $82.00; US NFP awaitedSilver (XAG/USD) steadies following the previous day's modest pullback from the $84.00 mark and trades with a mild positive bias during the Asian session on Wednesday.
Author  FXStreet
Feb 11, Wed
Silver (XAG/USD) steadies following the previous day's modest pullback from the $84.00 mark and trades with a mild positive bias during the Asian session on Wednesday.
placeholder
WTI drops below $64.00, Middle East tensions in focusWest Texas Intermediate (WTI), the US crude oil benchmark, is trading around $63.80 during the early Asian trading hours on Tuesday. The WTI price falls as concerns about supply disruptions in the Middle East have faded.
Author  FXStreet
Feb 10, Tue
West Texas Intermediate (WTI), the US crude oil benchmark, is trading around $63.80 during the early Asian trading hours on Tuesday. The WTI price falls as concerns about supply disruptions in the Middle East have faded.
placeholder
Silver price today: Silver rises, according to FXStreet dataSilver prices (XAG/USD) rose on Monday, according to FXStreet data. Silver trades at $81.78 per troy ounce, up 5.54% from the $77.48 it cost on Friday.
Author  FXStreet
Feb 09, Mon
Silver prices (XAG/USD) rose on Monday, according to FXStreet data. Silver trades at $81.78 per troy ounce, up 5.54% from the $77.48 it cost on Friday.
placeholder
Crypto Majors Stall as Bitcoin, Ether, and XRP Struggle to Shake Off Bearish OverhangBitcoin steadies at $70k while Ethereum and XRP face key resistance levels; technicals show bearish MACD crossovers despite oversold RSI conditions.
Author  Mitrade
Feb 09, Mon
Bitcoin steadies at $70k while Ethereum and XRP face key resistance levels; technicals show bearish MACD crossovers despite oversold RSI conditions.
goTop
quote